Based on the findings with our patient and our institutional cohort, we suggest that it is justified to deviate from “on‐size‐fits‐all” protocols and attempt a trial of aggressive management of SHP in patients with difficult to manage ESA‐resistant anemia and more modest PTH elevation. Here, PTH is linked to anemia.